News
Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...
Stocktwits on MSN13h
Why Weight-Loss Drugmaker Novo Nordisk’s Stock Is Rising Premarket Today
Novo Nordisk shares climbed in premarket trading Monday after the U.S. Food and Drug Administration granted accelerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback